Low serum copeptin levels in patients with obstructive sleep apnea

Sleep and Breathing

Volumn 17, Issue 4, 2013, Pages 1187-1192

  Ozben, Serkan ^a   Guvenc, Tolga Sinan ^a   Huseyinoglu, Nergiz ^a   Sanivar, Hilal Safak ^a   Hanikoglu, Ferhat ^b   Cort, Aysegul ^b   Ozben, Tomris ^b  

^a KAFKAS UNIVERSITY   (Turkey)

^b AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Antidiuretic hormone; Cardiovascular diseases; Copeptin; Obstructive sleep apnea

Indexed keywords

COPEPTIN; BIOLOGICAL MARKER; GLYCOPEPTIDE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL EVALUATION; CONTROLLED STUDY; DIET RESTRICTION; ENZYME IMMUNOASSAY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING; BLOOD; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHIES; INTRACRANIAL ARTERIOSCLEROSIS; MIDDLE AGED; REFERENCE VALUE; RISK FACTOR; SLEEP APNEA, OBSTRUCTIVE; TURKEY;

ADULT; BIOMARKERS; BODY MASS INDEX; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHIES; FEMALE; GLYCOPEPTIDES; HUMANS; HYPERTENSION; IMMUNOENZYME TECHNIQUES; INTRACRANIAL ARTERIOSCLEROSIS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; REFERENCE VALUES; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; TURKEY;

EID: 84888645145     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-013-0822-7     Document Type: Article

References (23)

1. Oktay B, Akbal E, Firat H, Ardic S, Akdemir R, Kizilgun M (2008) Evaluation of the relationship between heart type fatty acid binding protein levels and the risk of cardiac damage in patients with obstructive sleep apnea syndrome. Sleep Breath 12:223-228
2. Quercioli A, Mach F, Montecucco F (2010) Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS). Sleep Breath 14:261-269
3. Ursavas A, Karadag M, Gullulu M, Demirdogen E, Coskun F, Onart S, Gozu RO (2008) Low-grade urinary albumin excretion in normotensive/non-diabetic obstructive sleep apnea patients. Sleep Breath 12:217-222
4. Petrosyan M, Perraki E, Simoes D, Koutsourelakis I, Vagiakis E, Roussos C, Gratziou C (2008) Exhaled breath markers in patients with obstructive sleep apnoea. Sleep Breath 12:207-215
5. Khassawneh B, Ghazzawi M, Khader Y, Alomari M, Amarin Z, Shahrour B, Hammouda M (2009) Symptoms and risk of obstructive sleep apnea in primary care patients in Jordan. Sleep Breath 13:227-232
6. Cifçi N, Uyar M, Elbek O, Süyür H, Ekinci E (2010) Impact of CPAP treatment on cardiac biomarkers and pro-BNP in obstructive sleep apnea syndrome. Sleep Breath 14:241-244
7. Wang Y, Li Y, Chen P, Luo Y, Yang Y, Yang Y (2012) Elevated fractalkine in patients with obstructive sleep apnea hypopnea syndrome. Sleep Breath. doi: 10.1007/s11325-012-0674-6
8. Potocki M, Reichlin T, Thalmann S, Zellweger C, Twerenbold R, Reiter M, Steuer S, Bassetti S, Drexler B, Stelzig C, Freese M, Winkler K, Haaf P, Balmelli C, Hochholzer W, Osswald S, Mueller C (2012) Diagnostic and prognostic impact of copeptin and high-sensitivity cardiac troponin T in patients with pre-existing coronary artery disease and suspected acute myocardial infarction. Heart 98:558-565
9. Tentzeris I, Jarai R, Farhan S, Perkmann T, Schwarz MA, Jakl G, Wojta J, Huber K (2011) Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure. Eur J Heart Fail 13:726-733
10. Katan M, Fluri F, Morgenthaler NG, Schuetz P, Zweifel C, Bingisser R, Müller K, Meckel S, Gass A, Kappos L, Steck AJ, Engelter ST, Müller B, Christ-Crain M (2009) Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Ann Neurol 66:799-808
11. Enhörning S, Wang TJ, Nilsson PM, Almgren P, Hedblad B, Berglund G, Struck J, Morgenthaler NG, Bergmann A, Lindholm E, Groop L, Lyssenko V, Orho-Melander M, Newton-Cheh C, Melander O (2010) Plasma copeptin and the risk of diabetes mellitus. Circulation 121:2102-2108
12. Zhu XD, Chen JS, Zhou F, Liu QC, Chen G, Zhang JM (2011) Detection of copeptin in peripheral blood of patients with aneurysmal subarachnoid hemorrhage. Crit Care 15:R288
13. Morgenthaler NG, Struck J, Alonso C, Bergmann A (2006) Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 52:112-119
14. Iber C, Ancoli-Israel S, Chesson A, Quan SF (2007) The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, 1st edn. Westchester, Illinois
15. (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 22:667-689
16. Kiely JL, McNicholas WT (2000) Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur Respir J 16:128-133
17. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL (2002) Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165:677-682
18. Marin JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046-1053
19. Zweifel C, Katan M, Schuetz P, Siegemund M, Morgenthaler NG, Merlo A, Mueller B, Christ-Crain M (2010) Copeptin is associated with mortality and outcome in patients with acute intracerebral hemorrhage. BMC Neurol 10:34
20. Umlauf M, Chasens E, Greevy R, Arnold J, Burgio K, Pillion D (2004) Obstructive sleep apnea nocturia and polyuria in older adults. Sleep 27:139-144
21. Umlauf M, Chasens ER (2003) Sleep disordered breathing and nocturnal polyuria: nocturia and enuresis. Sleep Med Rev 7:403-411
22. Ichioka M, Hirata Y, Inase N, Tojo N, Yoshizawa M, Chida M, Miyazato I, Taniai S, Marumo F (1992) Changes of circulating atrial natriuretic peptide and antidiuretic hormone in obstructive sleep apnea syndrome. Respiration 59:164-168
23. Krieger J, Follenius M, Sforza E, Brandenberger G, Peter JD (1991) Effects of treatment with nasal continuous positive airway pressure on atrial natriuretic peptide and arginine vasopressin release during sleep in patients with obstructive sleep apnoea. Clin Sci (Lond) 80:443-449